Adage Capital Partners’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Hold |
2,000,000
| – | – | ﹤0.01% | 778 |
|
|
2025
Q1 | $1.3M | Hold |
2,000,000
| – | – | ﹤0.01% | 782 |
|
|
2024
Q4 | $3.68M | Sell |
2,000,000
-250,132
| -11% | -$460K | 0.01% | 745 |
|
|
2024
Q3 | $7.79M | Buy |
2,250,132
+250,132
| +13% | +$865K | 0.01% | 664 |
|
|
2024
Q2 | $5.86M | Hold |
2,000,000
| – | – | 0.01% | 693 |
|
|
2024
Q1 | $11.3M | Sell |
2,000,000
-2,467,796
| -55% | -$13.9M | 0.02% | 576 |
|
|
2023
Q4 | $19.2M | Buy |
4,467,796
+1,362,664
| +44% | +$5.85M | 0.04% | 432 |
|
|
2023
Q3 | $10.8M | Buy |
3,105,132
+2,879,412
| +1,276% | +$9.99M | 0.02% | 545 |
|
|
2023
Q2 | $1.05M | Buy |
225,720
+170,000
| +305% | +$791K | ﹤0.01% | 765 |
|
|
2023
Q1 | $257K | Buy |
+55,720
| New | +$257K | ﹤0.01% | 830 |
|
|
2022
Q1 | – | Sell |
-160,000
| Closed | -$2.38M | – | 1131 |
|
|
2021
Q4 | $2.38M | Sell |
160,000
-115,000
| -42% | -$1.71M | ﹤0.01% | 864 |
|
|
2021
Q3 | $5.2M | Sell |
275,000
-50,000
| -15% | -$945K | 0.01% | 829 |
|
|
2021
Q2 | $6.04M | Sell |
325,000
-125,300
| -28% | -$2.33M | 0.01% | 795 |
|
|
2021
Q1 | $10.2M | Sell |
450,300
-24,700
| -5% | -$562K | 0.02% | 665 |
|
|
2020
Q4 | $10.3M | Sell |
475,000
-250,000
| -34% | -$5.43M | 0.02% | 582 |
|
|
2020
Q3 | $7.29M | Hold |
725,000
| – | – | 0.02% | 573 |
|
|
2020
Q2 | $5.63M | Buy |
725,000
+300,000
| +71% | +$2.33M | 0.01% | 605 |
|
|
2020
Q1 | $4.34M | Buy |
425,000
+400,000
| +1,600% | +$4.08M | 0.01% | 591 |
|
|
2019
Q4 | $275K | Buy |
+25,000
| New | +$275K | ﹤0.01% | 706 |
|